Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-24 4:23 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 30-Jan-24 | Sale (Planned) | 971 | $65.53 | $63,629.60 | (2%) 58.18K to 57.21K | |
| 31-Jan-24 4:23 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 279 | $64.14 | $17,894.60 | (< 1%) 58.46K to 58.18K | |
| 24-Jan-24 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Jan-24 | Private Sale (Planned) | 7,378 | $63.69 | $469,905.00 | (11%) 65.84K to 58.46K | |
| 23-Jan-24 6:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 1,607 | $65.00 | $104,449.00 | (2%) 67.44K to 65.84K | |
| 18-Jan-24 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jan-24 | Private Sale (Planned) | 5,207 | $65.58 | $341,475.00 | (7%) 72.65K to 67.44K | |
| 17-Jan-24 12:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 19,508 | -- | -- | 36% 53.58K to 73.09K | |
| 17-Jan-24 12:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 438 | $66.81 | $29,262.20 | (< 1%) 73.09K to 72.65K | |
| 28-Dec-23 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Dec-23 | Sale (Planned) | 235 | $60.23 | $14,154.00 | (< 1%) 53.81K to 53.58K | |
| 28-Dec-23 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 26-Dec-23 | Private Sale | 68 | $57.86 | $3,934.54 | (< 1%) 53.88K to 53.81K | |
| 27-Feb-23 4:34 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Feb-23 | Private Sale (Planned) | 1,646 | $68.76 | $113,179.00 | (3%) 55.53K to 53.88K | |
| 22-Feb-23 6:46 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 9,886 | -- | -- | 21% 46.47K to 56.35K | |
| 22-Feb-23 6:46 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 825 | $58.50 | $48,262.50 | (1%) 56.35K to 55.53K | |
| 31-Jan-23 4:51 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 30-Jan-23 | Private Sale (Planned) | 883 | $52.76 | $46,587.10 | (2%) 47.35K to 46.47K | |
| 30-Jan-23 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 367 | $52.77 | $19,366.60 | (< 1%) 47.72K to 47.35K | |
| 25-Jan-23 4:14 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Jan-23 | Private Sale (Planned) | 4,479 | $51.58 | $231,027.00 | (9%) 52.2K to 47.72K | |
| 24-Jan-23 5:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 2,033 | $52.05 | $105,818.00 | (4%) 54.23K to 52.2K | |
| 17-Jan-23 7:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 22,580 | -- | -- | 71% 31.65K to 54.23K | |
| 23-Dec-22 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Dec-22 | Payment of Exercise | 89 | $51.68 | $4,599.52 | (< 1%) 31.74K to 31.65K | |
| 23-Dec-22 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Apr-22 | Disposition (other) | 1,250 | -- | -- | (4%) 32.99K to 31.74K | |
| 01-Feb-22 6:09 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 434 | $38.59 | $16,748.10 | (1%) 33.42K to 32.99K | (15%) |
| 25-Jan-22 4:50 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 26,051 | -- | -- | 353% 7.37K to 33.42K | |
| 23-Dec-21 4:49 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Dec-21 | Payment of Exercise | 89 | $47.82 | $4,255.98 | (1%) 7.46K to 7.37K | 0% |
| 03-Mar-21 4:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-21 | Grant | 1,250 | -- | -- | 20% 6.21K to 7.46K | |
| 01-Feb-21 4:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 5,000 | -- | -- | 413% 1.21K to 6.21K | |
| 23-Dec-20 5:41 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Dec-20 | Grant | 1,211 | -- | -- | 100% 0 to 1.21K |